ইউরোপীয় ইউনিয়ন - এস্তোনীয় - EMA (European Medicines Agency)

sanofi pasteur - chimeric yellow fever dengue virus serotype 1 (live, attenuated), chimeric yellow fever dengue virus serotype 2 (live, attenuated), chimeric yellow fever dengue virus serotype 3 (live, attenuated), chimeric yellow fever dengue virus serotype 4 (live, attenuated) - dengue - vaktsiinid - dengvaxia is indicated for the prevention of dengue disease caused by dengue virus serotypes 1, 2, 3 and 4 in individuals 6 to 45 years of age with test-confirmed previous dengue infection (see sections 4. 2, 4. 4 ja 4. kasutada dengvaxia peab olema kooskõlas ametlike soovitustega.

ইউরোপীয় ইউনিয়ন - এস্তোনীয় - EMA (European Medicines Agency)

astrazeneca ab - fulvestrant - rinnanäärmed - endokriinse ravi, anti-östrogeene - faslodex is indicated , as monotherapy for the treatment of estrogen receptor positive, locally advanced or metastatic breast cancer in postmenopausal women:, , not previously treated with endocrine therapy, or, with disease relapse on or after adjuvant antiestrogen therapy, or disease progression on antiestrogen therapy. , , , in combination with palbociclib for the treatment of hormone receptor (hr)-positive, human epidermal growth factor receptor 2 (her2)-negative locally advanced or metastatic breast cancer in women who have received prior endocrine therapy. , pre - või perimenopausal naiste kombineeritud ravi palbociclib tuleks koos luteiniseeriva hormooni vabastav hormoon (lhrh) agonist.

ইউরোপীয় ইউনিয়ন - এস্তোনীয় - EMA (European Medicines Agency)

novartis ireland ltd - ofatumumab - sclerosis multiplex, relapsing-remitting - immunosuppressant - kesimpta is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features (see section 5.

ইউরোপীয় ইউনিয়ন - এস্তোনীয় - EMA (European Medicines Agency)

takeda gmbh - dengue virus, serotype 2, expressing dengue virus, serotype 1, surface proteins, live, attenuated, dengue virus, serotype 2, expressing dengue virus, serotype 3, surface proteins, live, attenuated, dengue virus, serotype 2, expressing dengue virus, serotype 4, surface proteins, live, attenuated, dengue virus, serotype 2, live, attenuated - dengue - vaktsiinid - qdenga is indicated for the prevention of dengue disease in individuals from 4 years of age. the use of qdenga should be in accordance with official recommendations.

এস্তোনিয়া - এস্তোনীয় - Ravimiamet

oao monfarm - naatriummetamisool - tablett - 500mg 10tk

এস্তোনিয়া - এস্তোনীয় - Ravimiamet

oao monfarm - metüüluratsiil - rektaalsuposiit - 500mg 10tk

এস্তোনিয়া - এস্তোনীয় - Ravimiamet

oao monfarm - metüüluratsiil - tablett - 500mg 10tk

এস্তোনিয়া - এস্তোনীয় - Ravimiamet

oao monfarm - kseroform+tsinksulfaat+belladonnaekstrakt - rektaalsuposiit - 10tk

এস্তোনিয়া - এস্তোনীয় - Ravimiamet

oao monfarm - astelpaju õli - rektaalsuposiit - 500mg 10tk

এস্তোনিয়া - এস্তোনীয় - Ravimiamet

oao monfarm - bisakodüül - rektaalsuposiit - 10mg 10tk